» Articles » PMID: 39498407

Joint Association of Serum Sodium and Frailty with Mild Cognitive Impairment Among Hospitalized Older Adults with Chronic Diseases: a Cross-sectional Study

Overview
Journal Front Nutr
Date 2024 Nov 5
PMID 39498407
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To examine the associations of serum sodium and frailty with the risk of mild cognitive impairment (MCI) among hospitalized older adults with chronic diseases.

Methods: A cross-sectional study was conducted in 403 hospitalized older adults with chronic diseases. Serum sodium concentration was assessed by the ion-selective electrode method, frailty status was evaluated by the FRAIL scale, and MCI was determined by the Montreal Cognitive Assessment (MoCA). Multiple logistic regression models were used to estimate the associations of serum sodium and frailty with MCI.

Results: Participants with the lowest tertile of serum sodium had a higher risk of MCI than those in the middle tertile group (OR = 1.75, 95% CI: 1.01-3.04). Below 143 mmol/L, the risk of MCI was 1.38 (95% CI: 1.03-1.84) for per 1 SD decrease in serum sodium. Compared with the robust group, frailty was significantly associated with an increased risk of MCI (OR = 3.94, 95% CI: 1.92-8.10). Moreover, in comparison with participants with the middle tertile of serum sodium and who were robust/prefrail, those with frailty and either the lowest (OR = 5.53, 95% CI: 2.08-14.67) or the highest tertile of serum sodium (OR = 3.48, 95% CI: 1.20-10.05) had higher risks of MCI.

Conclusion: Both lower and higher serum sodium impose a significantly higher risk for MCI in older adults with frailty. This could inform the design of clinical trials and the development of guidelines and recommendations for correcting serum sodium and frailty in hospitalized older adults with chronic diseases.

References
1.
Huang D, Zhu J, Xu G, Zhang L, Chen X, Wang Y . Sodium chloride alleviates oxidative stress and physiological responses induced by extreme winter cold in genetically improved farmed tilapia (GIFT; Oreochromis niloticus). Sci Total Environ. 2023; 904:166800. DOI: 10.1016/j.scitotenv.2023.166800. View

2.
Islam N, Hashem R, Gad M, Brown A, Levis B, Renoux C . Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta-analysis. Alzheimers Dement. 2023; 19(7):3235-3243. DOI: 10.1002/alz.13040. View

3.
Tobeh N, Bruce K . Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions. Front Aging Neurosci. 2023; 15:1259012. PMC: 10630922. DOI: 10.3389/fnagi.2023.1259012. View

4.
Vatic M, von Haehling S, Ebner N . Inflammatory biomarkers of frailty. Exp Gerontol. 2020; 133:110858. DOI: 10.1016/j.exger.2020.110858. View

5.
. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022; 7(2):e105-e125. PMC: 8810394. DOI: 10.1016/S2468-2667(21)00249-8. View